Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 6/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.45 |
| ▸ | TYR | P14679 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 7/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
| ▸ | CASP7 | P55210 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL370841 | 0.84 | TDP1 (0.35) | ALOX5CYP3A4TYRMAPTMEN1 | |
| SCHEMBL27671187 | 0.83 | LIPG (0.38) | ALOX5CYP3A4TYRMAPTMEN1 | |
| SCHEMBL28300224 | 0.83 | LIPG (0.38) | ALOX5CYP3A4TYRMAPTMEN1 | |
| SCHEMBL28300226 | 0.83 | LIPG (0.38) | ALOX5CYP3A4TYRMAPTMEN1 | |
| Bromide SCHEMBL28162683 | 0.81 | LIPG (0.37) | ALOX5CYP3A4TYRMAPTMEN1 | |
| Bromide SCHEMBL28162087 | 0.81 | LIPG (0.37) | ALOX5CYP3A4TYRMAPTMEN1 | |
| Bromide SCHEMBL28162693 | 0.81 | LIPG (0.37) | ALOX5CYP3A4TYRMAPTMEN1 | |
| Pyrrole SCHEMBL28216728 | 0.80 | ALOX5 (0.34) | ALOX5TDP1PTGS2 | |
| SCHEMBL7016897 | 0.79 | HRH3 (0.38) | TYRALDH1A1 | |
| SCHEMBL6264510 | 0.77 | HCAR2 (0.35) | ALOX5CYP3A4TDP1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220184217-A1 | HSP90-BINDING CONJUGATES AND FORMULATIONS THEREOF | Fusion Pharmaceuticals Inc. (CA) | 2022-06-16 | — | — | US | disclosed |
| EP-3946320-A1 | HSP90-BINDING CONJUGATES AND FORMULATIONS THEREOF | Tarveda Therapeutics, Inc. (US) | 2022-02-09 | — | — | EP | disclosed |
| US-11241500-B2 | HSP90-targeting conjugates and formulations thereof | TARVEDA THERAPEUTICS, INC. (US) | 2022-02-08 | — | — | US | disclosed |
| US-20220031853-A1 | HSP90-TARGETING CONJUGATES AND FORMULATIONS THEREOF | TVA (ABC), LLC | 2022-02-03 | — | — | US | disclosed |
| WO-2021202830-A2 | HSP90-BINDING CONJUGATES AND FORMULATIONS THEREOF | TARVEDA THERAPEUTICS, INC. (US) | 2021-10-07 | — | — | WO | disclosed |
| EP-3849546-A1 | HSP90-TARGETING CONJUGATES AND FORMULATIONS THEREOF | Tarveda Therapeutics, Inc. (US) | 2021-07-21 | — | — | EP | disclosed |
| US-20210145971-A1 | HSP90-TARGETING CONJUGATES AND FORMULATIONS THEREOF | Fusion Pharmaceuticals Inc. (CA) | 2021-05-20 | — | — | US | disclosed |
| EP-3773670-A1 | HSP90-TARGETING CONJUGATES AND FORMULATIONS THEREOF | Tarveda Therapeutics, Inc. (US) | 2021-02-17 | — | — | EP | disclosed |
| US-20210000966-A1 | HSP90-TARGETING CONJUGATES AND FORMULATIONS THEREOF | TVA (ABC), LLC | 2021-01-07 | — | — | US | disclosed |
| CN-112074288-A | HSP 90-targeting conjugates and formulations thereof | 塔弗达治疗有限公司 | 2020-12-11 | — | — | CN | disclosed |
| WO-2012084602-A1 | ARYL TRIAZOLE COMPOUNDS WITH ANTITUMOURAL ACTIVITY | SIGMA-TAU RESEARCH SWITZERLAND S.A. (CH) | 2012-06-28 | — | — | WO | disclosed |
| US-20120022026-A1 | METHOD OF TREATING CANCER | ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM (NL) | 2012-01-26 | — | — | US | disclosed |
| EP-2387403-A1 | METHOD OF TREATING CANCER | Academisch Medisch Centrum bij de Universiteit van Amsterdam (NL) | 2011-11-23 | — | — | EP | disclosed |
| US-20110253692-A1 | Electrical heater for vehicle windshields and windows | SCHAUBLE RICHARD EGON | 2011-10-20 | — | — | US | disclosed |
| US-20110245221-A1 | ARYL ISOXAZOLE COMPOUNDS WITH ANTITUMOURAL ACTIVITIES | SIGMA-TAU RESEARCH SWITZERLAND S.A. (CH) | 2011-10-06 | — | — | US | disclosed |
| EP-2310377-A1 | 5-PHENYL-ISOXAZOLE-3-CARBOXAMIDES MODULATING HSP90 WITH ANTITUMORAL ACTIVITIES | SIGMA-TAU Research Switzerland S.A. (CH) | 2011-04-20 | — | — | EP | disclosed |
| CN-101983191-A | Oxim derivatives as hsp90 inhibitors | TAKEDA PHARMACEUTICAL | 2011-03-02 | — | — | CN | disclosed |
| WO-2010082821-A1 | METHOD OF TREATING CANCER | ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (NL) | 2010-07-22 | — | — | WO | disclosed |
| WO-2010082813-A1 | METHOD OF TREATING CANCER | ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (NL) | 2010-07-22 | — | — | WO | disclosed |
| WO-2010000748-A1 | 5-PHENYL-ISOXAZOLE-3-CARBOXAMIDES MODULATING HSP90 WITH ANTITUMORAL ACTIVITIES | SIGMA-TAU RESEARCH SWITZERLAND S.A. (CH) | 2010-01-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210000966-A1 | HSP90-TARGETING CONJUGATES AND FORMULATIONS THEREOF | HSP90AB1, HSP90AA1, HSP90B1 | ALOX5 4753/4885CYP3A4 4155/4885TYR 4109/4885 |
| US-20220184217-A1 | HSP90-BINDING CONJUGATES AND FORMULATIONS THEREOF | HSP90AB1, HSP90B1, HSP90AA1 | ALOX5 4741/4885CYP3A4 3955/4885TYR 4433/4885 |
| US-20110245221-A1 | ARYL ISOXAZOLE COMPOUNDS WITH ANTITUMOURAL ACTIVITIES | HSP90AB1, HSP90AB2P, HSP90AA1 | ALOX5 2495/4885CYP3A4 1796/4885TYR 434/4885 |
| US-11241500-B2 | HSP90-targeting conjugates and formulations thereof | HSP90AB1, HSP90AA1, HSP90B1 | ALOX5 4753/4885CYP3A4 4155/4885TYR 4109/4885 |
| US-20220031853-A1 | HSP90-TARGETING CONJUGATES AND FORMULATIONS THEREOF | HSP90AB1, HSP90AA1, HSP90B1 | ALOX5 4753/4885CYP3A4 4155/4885TYR 4109/4885 |
| US-20210145971-A1 | HSP90-TARGETING CONJUGATES AND FORMULATIONS THEREOF | HSP90AB1, HSP90B1, HSP90AA1 | ALOX5 4744/4885CYP3A4 4007/4885TYR 4326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.